BACKGROUND: The major characteristic of @entity1030 is systemic @entity32 . The parameters such as neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-basophil ratio (EBR) in routine blood test (RBT) are considered to be the underlying biomarkers of @entity32 . We hypothesized that the prognosis of @entity1 with @entity1030 can be predicted with RBT. METHODS: @entity1 with @entity1030 in stable stage were enrolled. The RBT, pulmonary function testing (PFT), BODE index, @entity1851 ( @entity1851 ), procalcitonin, and erythrocyte sedimentation rate (ESR) were performed at enrollment and every follow-up once in every 3 months during the 24-month follow-up period. Meanwhile, exacerbation count and mortality incidence were recorded. The correlation between the prognostic biomarkers and the prognosis of @entity1 was analyzed. RESULTS: The NLR and EBR in RBT have a significant correlation with the severity of @entity1 with @entity1030 . The NLR is an independent predictor for mortality and the EBR is an independent predictor for exacerbation. CONCLUSION: As an inexpensive, accessible, and convenient assay, RBT may be used as a practical means in the prediction of prognosis of @entity1 with @entity1030 in future clinical settings.

Can we predict the prognosis of XXXX with a routine blood test?

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity32 :: ('MESH:D007249', 'Disease') :: ['inflammation'] @entity1851 :: ('1401', 'Gene') :: ['C-reactive protein', 'CRP'] @entity1030 :: ('MESH:D029424', 'Disease') :: ['COPD']
@entity1030 :: (MESH:D029424,Disease) :: ['COPD']
